Categorizing Patient Risk for Tricuspid Regurgitation (TR) Intervention With Admittance Pulmonary Artery Catheter System (APACS)

ConditionTricuspid Regurgitation (TR)

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorFeldman Cardiology, PLLC

About this trial

The study is focused on evaluation of the effectiveness of the Admittance Pulmonary Artery Catheter (PAC) system for assessing the right ventricular (RV) function in patients with tricuspid regurgitation (TR) prior to tricuspid valve intervention.

Eligibility criteria

Qualifiers

Patients with severe or torrential TR who are already scheduled to undergo clinically indicated tricuspid valve (TV) percutaneous replacement or clipping to reduce heart failure symptoms

Disqualifiers

Children (defined as individual <18 years of age) will be excluded from this study

Trial design

Treatments tested in this trial

Right Heart Catheterization

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Feldman Cardiology, PLLC

Lead sponsor

Source ClinicalTrials.gov